Impact of Glucoraphanin-Mediated Activation of Nrf2 on Non-Alcoholic Fatty Liver Disease with a Focus on Mitochondrial Dysfunction. Here, NFE2L2 is linked to metabolic dysfunction-associated steatotic liver disease.